New Quantum Holdings Announces Plans to Become Public in the USA
news Debbie A. Klis · Victoria Yang · Carl Sherer · Ivan Komaritsky · Craig Tanner · Robert (Bob) Cocchia · David Devernoe · Roy W. Gillig · Amy Baker · Anne Mitzelfelt · June 20, 2023
Rimon PC client, Canna-Global Acquisition Corp (“Canna-Global”) (NASDAQ:CNGL), a special purpose acquisition company, announced the signing of a definitive Bid Implementation and Business Acquisition Agreement with Sydney-based New Quantum Holdings Pty Ltd. (“New Quantum”), a provider of a vertically integrated technology and infrastructure offering for financial services firms, that will result in New Quantum becoming…
FDA Announces Pilot Program for Medical Device Submission with Health Canada but Spots Are Limited
insights Amy Baker · January 12, 2023
On January 10, 2023 the FDA announced that it has partnered with Health Canada to launch a joint eSTAR pilot. The pilot will allow medical device manufacturers to submit a premarket notice submission to FDA and Health Canada simultaneously. eSTAR initially debuted in 2020 for medical device submissions to FDA’s Center for Devices and Radiological…
Broadcast Retirement Network Interview: Classifying Aging as a Disease Could Speed FDA Drug Approvals
insights Amy Baker · January 9, 2023
Rimon attorney Amy Baker sat down with Jeffrey Snyder from the Broadcast Retirement Network to discuss the potential impact of classifying aging as a disease on FDA drug approvals. Watch the interview here. Find out more about the Broadcast Retirement Network here. Amy Baker is a Partner in Rimon’s Orlando office. Ms. Baker focuses…
Classifying aging as a disease could speed FDA drug approvals
innovation Amy Baker · Mark H. Mirkin · Steven Colby · David Devernoe · January 3, 2023
Article originally published by The Hill. Republished with permission from publisher. Authored by Rimon attorney, Amy Baker. Attorneys Mark H. Mirkin, Steven Colby, JD, Ph.D. and David Devernoe contributed to the piece. The Food and Drug Administration (FDA) considers aging to be a natural process. This makes it difficult to get FDA approval for drugs…
Rimon Advises Australian Oilseeds Investments Pty. Ltd. on its Business Combination Agreement with EDOC Acquisition Corp.
news Debbie A. Klis · Debra Vernon · Ivan Komaritsky · Victoria Yang · Craig Tanner · Amy Baker · Roy W. Gillig · Robert (Bob) Cocchia · Anne Mitzelfelt · December 8, 2022
Special purpose acquisition company, EDOC Acquisition Corp. (Nasdaq: ADOC, ADOCR, ADOCW, “EDOC”) announced yesterday that it has entered into a definitive business combination agreement with Rimon client Australian Oilseeds Investments Pty. Ltd. Upon the satisfaction of all closing conditions, the transaction will result in Australian Oilseeds Holdings Limited, a to-be-formed Cayman Islands company, listing its…
The FTC is holding company executives personally accountable for data breaches as part of an aggressive effort to protect consumer data
insights Amy Baker · November 9, 2022
The FTC is holding company executives personally accountable for data breaches as part of an aggressive effort to protect consumer data In a policy shift, the Federal Trade Commission (FTC) is targeting company executives in what it has described as “part of [its] aggressive efforts to ensure that companies are protecting consumers’ data and that…
Webinar: Intellectual Property Strategy for Innovative Companies – Patents, Copyrights, Trademarks and Other Considerations
events Amy Baker · David Devernoe · July 22, 2022
Intellectual Property Strategy for Innovative Companies – Patents, Copyrights, Trademarks and Other Considerations 4:00 PM – 5:00 PM EDT, July 26, 2022 For more information or to register, click here. Description: Navigating the world of Intellectual Property (IP) can be daunting for innovative companies, but it can also be imperative to success. In this webinar,…
Global law firm Rimon PC adds Amy Baker as Life Sciences Partner and opens new office in Orlando
news Amy Baker · May 31, 2022
Orlando, FL – Rimon, consistently recognized for its innovation and teamwork throughout its 46 offices is pleased to welcome life sciences attorney Amy Baker as a Partner in its new Orlando office. Ms. Baker joins Rimon from Wilson Elser Moskowitz Edelman & Dicker LLP, where she was a Partner and co-chair of the firm’s life…